Lipooligosaccharide is required for the generation of infectious elementary bodies in Chlamydia trachomatis | PNAS
Anti Chlamydia trachomatis LPS Antibody, clone 1312/236 | Bio-Rad
Rab6 and Rab11 Regulate Chlamydia trachomatis Development and Golgin-84-Dependent Golgi Fragmentation | PLOS Pathogens
Immunoelectron microscopy of lipopolysaccharide in Chlamydia trachomatis. - Abstract - Europe PMC
KEGG PATHWAY: Lipopolysaccharide biosynthesis - Chlamydia trachomatis L2b/UCH-1/proctitis
Immunobiology of monocytes and macrophages during Chlamydia trachomatis infection - ScienceDirect
Modulation of host signaling and cellular responses by Chlamydia | Cell Communication and Signaling | Full Text
Schematic representation of a Chlamydia particle with different targets... | Download Scientific Diagram
Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction | Nature
Frontiers | Membrane vesicle production by Chlamydia trachomatis as an adaptive response
Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome | BMC Gastroenterology | Full Text
Anti Chlamydia LPS Antibody, clone CF 6J12 | Bio-Rad
Anti-Chlamydial LPS Antibody, clone EVI-H1 clone EVI-H1, from mouse | Sigma-Aldrich
Interaction of Chlamydiae with human macrophages - Herweg - 2016 - The FEBS Journal - Wiley Online Library
Frontiers | Genetic Inactivation of Chlamydia trachomatis Inclusion Membrane Protein CT228 Alters MYPT1 Recruitment, Extrusion Production, and Longevity of Infection
Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bow
Anti Chlamydia LPS Antibody, clone CF 6J12 | Bio-Rad
Male genital tract immune response against Chlamydia trachomatis infection in: Reproduction Volume 154 Issue 4 (2017)
Mouse Anti-Chlamydia LPS (1644) | MAB12271 | Native Antigen
Anti-Chlamydia trachomatis Antibody (A33620) | Antibodies.com
Vaccines | Free Full-Text | Potential Applications of Microparticulate-Based Bacterial Outer Membrane Vesicles (OMVs) Vaccine Platform for Sexually Transmitted Diseases (STDs): Gonorrhea, Chlamydia, and Syphilis
